Literature DB >> 20002045

5. Nonmalignant diseases after the Chernobyl catastrophe.

Alexey V Yablokov1.   

Abstract

This section describes the spectrum and the scale of the nonmalignant diseases that have been found among exposed populations. Adverse effects as a result of Chernobyl irradiation have been found in every group that has been studied. Brain damage has been found in individuals directly exposed--liquidators and those living in the contaminated territories, as well as in their offspring. Premature cataracts; tooth and mouth abnormalities; and blood, lymphatic, heart, lung, gastrointestinal, urologic, bone, and skin diseases afflict and impair people, young and old alike. Endocrine dysfunction, particularly thyroid disease, is far more common than might be expected, with some 1,000 cases of thyroid dysfunction for every case of thyroid cancer, a marked increase after the catastrophe. There are genetic damage and birth defects especially in children of liquidators and in children born in areas with high levels of radioisotope contamination. Immunological abnormalities and increases in viral, bacterial, and parasitic diseases are rife among individuals in the heavily contaminated areas. For more than 20 years, overall morbidity has remained high in those exposed to the irradiation released by Chernobyl. One cannot give credence to the explanation that these numbers are due solely to socioeconomic factors. The negative health consequences of the catastrophe are amply documented in this chapter and concern millions of people.

Entities:  

Mesh:

Year:  2009        PMID: 20002045     DOI: 10.1111/j.1749-6632.2009.04826.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Overestimation of Chernobyl consequences: poorly substantiated information published.

Authors:  Sergei V Jargin
Journal:  Radiat Environ Biophys       Date:  2010-07-17       Impact factor: 1.925

2.  Cellular Therapies for Treatment of Radiation Injury: Report from a NIH/NIAID and IRSN Workshop.

Authors:  Andrea L DiCarlo; Radia Tamarat; Carmen I Rios; Marc Benderitter; Christine W Czarniecki; Theresa C Allio; Francesca Macchiarini; Bert W Maidment; Jean-Rene Jourdain
Journal:  Radiat Res       Date:  2017-06-12       Impact factor: 2.841

3.  Pseudoloma neurophilia Infection Combined with Gamma Irradiation Causes Increased Mortality in Adult Zebrafish (Danio rerio) Compared to Infection or Irradiation Alone: New Implications for Studies Involving Immunosuppression.

Authors:  Sean T Spagnoli; Justin L Sanders; Virginia Watral; Michael L Kent
Journal:  Zebrafish       Date:  2016-04-28       Impact factor: 1.985

4.  Effects of long-term low-level radiation exposure after the Chernobyl catastrophe on immunoglobulins in children residing in contaminated areas: prospective and cross-sectional studies.

Authors:  Daria M McMahon; Vitaliy Y Vdovenko; Wilfried Karmaus; Valentina Kondrashova; Erik Svendsen; Oksana M Litvinetz; Yevgenia I Stepanova
Journal:  Environ Health       Date:  2014-05-10       Impact factor: 5.984

5.  Capacity of blood plasma is higher in birds breeding in radioactively contaminated areas.

Authors:  Magdalena Ruiz-Rodríguez; Anders P Møller; Timothy A Mousseau; Juan J Soler
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

6.  137Cesium exposure and spirometry measures in Ukrainian children affected by the Chernobyl nuclear incident.

Authors:  Erik R Svendsen; Igor E Kolpakov; Yevgenia I Stepanova; Vitaliy Y Vdovenko; Maryna V Naboka; Timothy A Mousseau; Lawrence C Mohr; David G Hoel; Wilfried J J Karmaus
Journal:  Environ Health Perspect       Date:  2010-01-25       Impact factor: 9.031

7.  Chronic exposure of adult, postnatal and in utero rat models to low-dose 137Cesium: impact on circulating biomarkers.

Authors:  Line Manens; Stéphane Grison; Jean-Marc Bertho; Philippe Lestaevel; Yann Guéguen; Marc Benderitter; Jocelyne Aigueperse; Maâmar Souidi
Journal:  J Radiat Res       Date:  2016-07-27       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.